The DOI matches its Crossref record; 141 of the 146 references it cites were found in a registry or an index, and 5 are not checked yet.
Immune Response, Inflammation, and the Clinical Spectrum of COVID-19
Open accessAbstract
The current COVID-19 pandemic began in December 2019 in Wuhan (China) and rapidly extended to become a global sanitary and economic emergency. Its etiological agent is the coronavirus SARS-CoV-2. COVID-19 presents a wide spectrum of clinical manifestations, which ranges from an asymptomatic infection to a severe pneumonia accompanied by multisystemic failure that can lead to a patient's death. The immune response to SARS-CoV-2 is known to involve all the components of the immune system that together appear responsible for viral elimination and recovery from the infection. Nonetheless, such immune responses are implicated in the disease's progression to a more severe and lethal process. This review describes the general aspects of both COVID-19 and its etiological agent SARS-CoV-2, stressing the similarities with other severe coronavirus infections, such as SARS and MERS, but more importantly, pointing toward the evidence supporting the hypothesis that the clinical spectrum of COVID-19 is a consequence of the corresponding variable spectrum of the immune responses to the virus. The critical point where progression of the disease ensues appears to center on loss of the immune regulation between protective and altered responses due to exacerbation of the inflammatory components. Finally, it appears possible to delineate certain major challenges deserving of exhaustive investigation to further understand COVID-19 immunopathogenesis, thus helping to design more effective diagnostic, therapeutic, and prophylactic strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Among them, IL-6 is a major player in chronic inflammatory diseases, autoimmune diseases, cancer and cytokine storm (1, 3, 10–26).”
From IL-6 in inflammation, autoimmunity and cancer (2021) · cites this paper as [16]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Consistent with the notion that severe COVID-19 is a cytokine storm syndrome (12–17, 336), the severity of COVID-19 is associated with an increased level of inflammatory cytokines, such as IL-6, granulocyte macrophage colony-stimulating factor (GM-CSF) and TNFα (333, 337).”
From IL-6 in inflammation, autoimmunity and cancer (2021) · cites this paper as [16]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“ARDS in COVID-19 is considered the result of cytokine storm (12–17), resembling the disease caused by SARS-CoV-1 and Middle East respiratory syndrome coronavirus (MERS-CoV) (335).”
From IL-6 in inflammation, autoimmunity and cancer (2021) · cites this paper as [16]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Wang, X., Xu, W., Hu, G., Xia, S., Sun, Z., Liu, Z., Xie, Y., Zhang, R., Jiang, S., & Lu, L. (2020) · Cellular and Molecular Immunology · doi:10.1038/s41423-020-0498-4 · Cited by 175
RetractedWang, X., Xu, W., Hu, G., Xia, S., Sun, Z., Liu, Z., Xie, Y., Zhang, R., Jiang, S., & Lu, L. (2020) · Cellular and Molecular Immunology · doi:10.1038/s41423-020-0424-9 · Cited by 162
RetractedClinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia
Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., Ren, R., Leung, K. S. M., Lau, E. H. Y., Wong, J. Y., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001316 · Cited by 16,575
A new coronavirus associated with human respiratory disease in China
Wu, F., Zhao, S., Yu, B., Chen, Y.-M., Wang, W., Song, Z.-G., Hu, Y., Tao, Z.-W., Tian, J.-H., Pei, Y.-Y., et al. (2020) · Nature · doi:10.1038/s41586-020-2008-3 · Cited by 11,688
COVID-19: consider cytokine storm syndromes and immunosuppression
Mehta, P., McAuley, D. F., Brown, M., Sanchez, E., Tattersall, R. S., & Manson, J. J. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30628-0 · Cited by 9,664
Flagged first, then by citations
Cited by
Sorted by citations
Items 301–400 of 740
Cao, Y., Lai, K. M., Fu, K.-C., Kuo, C.-L., Tan, Y., Yu, L. L., & Huang, D. (2024) · Foods · doi:10.3390/foods13203274 · Cited by 10
Lung microbiota dysbiosis and the implications of SARS-CoV-2 infection in pregnancy
Ezechukwu, H. C., Diya, C. A., Egoh, I. J., Abiodun, M. J., Grace, J.-U. A., Okoh, G. R., Adu, K. T., & Adegboye, O. A. (2021) · Therapeutic Advances in Infectious Disease · doi:10.1177/20499361211032453 · Cited by 10
The incidence of myopericarditis in patients with COVID-19
Mostafavi, A., Tabatabaei, S. A. H., Fard, S. Z., Majidi, F., Mohagheghi, A., & Shirani, S. (2021) · Journal of Cardiovascular and Thoracic Research · doi:10.34172/jcvtr.2021.36 · Cited by 10
Anti-inflammatory Effects of Different Dietary Antioxidants
Roy, A., Das, S., Chatterjee, I., Roy, S., & Chakraborty, R. (2022) · Reference series in phytochemistry · doi:10.1007/978-3-030-45299-5_20-1 · Cited by 10
Khanaliha, K., Nahand, J. S., Khatami, A., Mirzaei, H., Chavoshpour, S., Taghizadieh, M., Karimzadeh, M., Donyavi, T., & Bokharaei‐Salim, F. (2024) · Health Science Reports · doi:10.1002/hsr2.1861 · Cited by 10
Liu, Z., Wu, D., Xia, H., Jiang, W., Qiu, L., Tang, R., & Yu, X. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2020.107343 · Cited by 10
RETRACTED ARTICLE: Evaluation of ferritin level in COVID-19 patients and its inflammatory response
Chen, J., He, Z., & Wang, F.-K. (2022) · Applied Nanoscience · doi:10.1007/s13204-021-02115-9 · Cited by 10
RetractedThe viral phoenix: enhanced infectivity and immunity evasion of SARS-CoV-2 variants
Choi, H., Chatterjee, P., Hwang, M., Lichtfouse, E. A., Sharma, V. K., & Jinadatha, C. (2021) · Environmental Chemistry Letters · doi:10.1007/s10311-021-01318-4 · Cited by 10
Studying Humoral Immune Response at Mild and Asymptomatic COVID-19 Forms
Балахонов, С. В., Dubrovina, V. I., Chesnokova, M. V., Войткова, В. В., Борисовна, П. А., Bryukhova, D. D., Kiseleva, N. O., Михайлович, К. К., Kuznetsova, T. G., & Markevich, Z. V. (2020) · Бюллетень Восточно-Сибирского научного центра Сибирского отделения Российской академии медицинских наук · doi:10.29413/abs.2020-5.5.3 · Cited by 9
Al‐Qaaneh, A. M., Al-Ghamdi, F., AbdulAzeez, S., & Borgio, J. F. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14030624 · Cited by 9
A novel insight on SARS-CoV-2 S-derived fragments in the control of the host immunity
Bastos, T. S. B., de Paula, A. G. P., Luz, R. B. D. S., Garnique, A. M. B., Belo, M. A. D. A., Eto, S. F., Fernandes, D. C., Ferraris, F. K., de Pontes, L. G., França, T. T., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-29588-8 · Cited by 9
Agudelo, J. S. H., Ayala‐Zapata, S., Badiel, M., Zea-Vera, A. F., & Matta, L. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e24099 · Cited by 9
Critical care triage during the COVID-19 pandemic in South Africa: A constitutional imperative!
Morrow, B. M., Gopalan, P., Joubert, I., Paruk, F., & Pope, A. (2020) · South African Medical Journal · doi:10.7196/samj.2020.v110i12.15411 · Cited by 9
sMAdCAM: IL-6 Ratio Influences Disease Progression and Anti-Viral Responses in SARS-CoV-2 Infection
Jagtap, D. D., Bhor, V. M., Bhowmick, S., Kasarpalkar, N., Sagvekar, P., Kulkarni, B. J., Pathak, M., Chatterjee, N., Dolas, P., Palav, H. C., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.619906 · Cited by 10
Razi, O., Tartibian, B., Teixeira, A. M., Zamani, N., Govindasamy, K., Suzuki, K., Laher, I., & Zouhal, H. (2022) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2022.103557 · Cited by 10
Amazonian fruits with potential effects on COVID‐19 by inflammaging modulation: A narrative review
Mânica-Cattani, M. F., Hoefel, A. L., Azzolin, V. F., Montano, M. A. E., Jung, I. E. D. C., Ribeiro, E. E., Azzolin, V. F., & da Cruz, I. B. M. (2022) · Journal of Food Biochemistry · doi:10.1111/jfbc.14472 · Cited by 9
de Oliveira, L. C. G., Cruz, N. A. N., Ricelli, B., Junior, H. T. S., Medina-Pestana, J. O., & Casarini, D. E. (2021) · The Journal of venomous animals and toxins including tropical diseases · doi:10.1590/1678-9199-jvatitd-2020-0181 · Cited by 9
Impaired activation of Transposable Elements in SARS-CoV-2 infectionPreprint
Sorek, M., Meshorer, E., & Schlesinger, S. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.02.25.432821 · Cited by 9
Temerozo, J. R., Sacramento, C. Q., Fintelman-Rodrigues, N., Pão, C. R. R., de Freitas, C. S., Dias, S. S. G., Ferreira, A. C., Mattos, M., Soares, V. C., Teixeira, L., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.07.25.220806 · Cited by 9
Coronavirus - A Crippling Affliction to Humans
Kaul, R., & Devi, S. (2022) · Recent Patents on Biotechnology · doi:10.2174/1872208316666220404103033 · Cited by 8
Developing dendritic cell for SARS-CoV-2 vaccine: Breakthrough in the pandemic
Jonny, J., Putranto, T. A., Irfon, R., & Sitepu, E. C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.989685 · Cited by 13
Wang, Y., Li, P., Lavrijsen, M., Rottier, R. J., den Hoed, C. M., Bruno, M. J., Kamar, N., Peppelenbosch, M. P., de Vries, A. C., & Pan, Q. (2023) · United European Gastroenterology Journal · doi:10.1002/ueg2.12417 · Cited by 8
Catalase Activity of IgGs of Patients Infected with SARS-CoV-2
Tolmacheva, A. S., Onvumere, M. K., Sedykh, S. E., Timofeeva, A. M., & Nevinsky, G. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241210081 · Cited by 8
Dewi, I. P., Dachriyanus, D., Aldi, Y., Ismail, N. H., Hefni, D., Susanti, M., Putra, P. P., & Wahyuni, F. S. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.117381 · Cited by 9
Immunomodulation and immunotherapeutics of COVID-19
Garg, S. S., Sharma, A., & Gupta, J. (2021) · Clinical Immunology · doi:10.1016/j.clim.2021.108842 · Cited by 8
Early Prediction of Severe COVID-19 in Patients by a Novel Immune-Related Predictive Model
Sun, C., Xue, M., Yang, M. J., Zhu, L., Zhao, Y., Lv, X., Lin, Y., Ma, D., Shen, X., Cheng, Y., et al. (2021) · mSphere · doi:10.1128/msphere.00752-21 · Cited by 8
Extra-Articular Manifestations in Reactive Arthritis due to COVID-19
Santacruz, J. C., Londoño, J. D., Santos, A. M., Arzuaga, Á., & Mantilla, M. J. (2021) · Cureus · doi:10.7759/cureus.18620 · Cited by 8
Levilimab in patients with COVID-19 in real-life practice
Tavlueva, E. V., Ivanov, I., Lytkina, K., Plesovskiy, P. A., Безуглая, Т. В., Fridman, S. R., Meleshkevich, T. A., Strizheletskiy, V. V., Melkonyan, G. G., Melik-Ogandzhanyan, G. Y., et al. (2021) · Clinical pharmacology and therapy · doi:10.32756/0869-5490-2021-3-31-37 · Cited by 8
Singh, G., Rumende, C. M., Sharma, S. K., Rengganis, I., Amin, Z., Loho, T., Hermiyanti, E., Harimurti, K., & Wibowo, H. (2022) · Annals of Medicine · doi:10.1080/07853890.2022.2095012 · Cited by 8
Insights into organoid-based modeling of COVID-19 pathology
Boroojerdi, M. H., Jabry, T. A., Mirarefin, S. M. J., & Albalushi, H. M. A. (2023) · Virology Journal · doi:10.1186/s12985-023-01996-2 · Cited by 10
‘BhAVI-23’-A spice-herb based dietary infusion possessing in-vitro anti-viral potential
Saxena, S., Kumar, S., Hajare, S. N., Gupta, S., Gautam, S., & Ghosh, S. K. (2021) · Journal of Ayurveda and Integrative Medicine · doi:10.1016/j.jaim.2020.11.005 · Cited by 8
Banerjee, U., Chunchanur, S. K., Ambica, R., Balaji, K. N., Singh, A., Chakravortty, D., & Chandra, N. R. (2023) · Genes and Immunity · doi:10.1038/s41435-023-00210-1 · Cited by 7
Volis, I., Livneh, I., Hussein, K., & Raz-Pasteur, A. (2020) · American Journal of the Medical Sciences · doi:10.1016/j.amjms.2020.11.001 · Cited by 7
Açıksarı, G., Çetinkal, G., Koçak, M., Çağ, Y., Atıcı, A., Altunal, L. N., Barman, H. A., Aydın, M., Koçaş, B. B., Cam, G., et al. (2021) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2021.06.001 · Cited by 7
IgM-enriched immunoglobulin in COVID-19: Case series of 15 severely ill SARS-CoV-2-infected patients
Tabarsi, P., Hashemian, S. M. R., Bauhofer, A., Savadkoohi, A. A., Ghadimi, S., Haseli, S., & Dastan, F. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107998 · Cited by 7
Therapeutic Options for Coronavirus Disease 2019 (COVID-19): Where Are We Now?
Golnabi, E. Y., Sanders, J. M., Johns, M. L., Lin, K., Ortwine, J. K., Wei, W., Mang, N. S., & Cutrell, J. B. (2021) · Current Infectious Disease Reports · doi:10.1007/s11908-021-00769-8 · Cited by 7
Blood filters in children with COVID ‐19 and acute kidney injury: A review
Raina, R., Sethi, S. K., Chakraborty, R., Singh, S., Teo, S., Khooblall, A., Montini, G., Bunchman, T. E., Topaloğlu, R., & Yap, H. K. (2022) · Therapeutic Apheresis and Dialysis · doi:10.1111/1744-9987.13793 · Cited by 7
Thirupataiah, B., Bhuktar, H., Mounika, G., Reddy, G. S., Kumar, J. S., Shukla, S., Hossain, K. A., Medishetti, R., Samarpita, S., Rasool, M., et al. (2022) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2022.105667 · Cited by 7
Tegeler, C. M., Bilich, T., Maringer, Y., Salih, H. R., Walz, J. S., Nelde, A., & Heitmann, J. S. (2022) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2022.04.019 · Cited by 10
Association of Interleukin‐17F Polymorphism and Mortality Predictors with the Risk of COVID‐19
El-Desoky, M. M., Tharwat, S., Mostafa, N., Hewidy, A. A., Elmorsey, R. A., Abdelhafez, M. S., El-Ashry, A. H., Elhendawi, M., Fathy, A. A., & Hisham, F. A. (2022) · International Journal of Clinical Practice · doi:10.1155/2022/4761631 · Cited by 7
A Case of a Malignant Lymphoma Patient Persistently Infected with SARS-CoV-2 for More than 6 Months
Nagasaki, Y., Kadowaki, M., Nakamura, A., Etoh, Y., Shimo, M., Ishihara, S., Arimizu, Y., Iwamoto, R., Kamamuta, S., & Iwasaki, H. (2023) · Medicina · doi:10.3390/medicina59010108 · Cited by 7
SARS-CoV-2 ORF8 as a Modulator of Cytokine Induction: Evidence and Search for Molecular Mechanisms
Móvio, M. I., de Almeida, G. W. C., Martines, I. G. L., de Lima, G. B., Sasaki, S. D., Kihara, A. H., Poole, E. L., Nevels, M. M., & da Silva, M. C. C. (2024) · Viruses · doi:10.3390/v16010161 · Cited by 7
Lindo, J., Nogueira, C., Soares, R., Cunha, N., Almeida, M. R., Rodrigues, L., COELHO, P. M. D. S. C., Rodrigues, F., Cunha, R. A., & Gonçalves, T. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25116135 · Cited by 7
Guerin, P. J., McLean, A. R. D., Rashan, S., Lawal, A., Watson, J. A., Wourgaft, N. S., & White, N. J. (2021) · medRxiv · doi:10.1101/2021.06.04.21257852 · Cited by 7
Popova, A. Y., Ezhlova, E. B., Melnikova, A. A., Istorik, O. A., Mosevich, O. S., Лялина, Л. В., Смирнов, В. С., Черный, М., Балабашыва, Н., Loginova, I. S., et al. (2020) · doi:10.21055/preprints-3111753 · Cited by 7
Villemure, S. E., Trenaman, S. C., & Goralski, K. B. (2023) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2023.2228680 · Cited by 7
Tehrani, S. O., Rahbardar, M. G., Shoorgashti, K., Nayeri, M. J. D., Mohammadpour, A. H., & Hosseinzadeh, H. (2023) · PubMed Central · doi:10.22038/ajp.2022.21539 · Cited by 6
Brown, G., Marchwicka, A., & Marcinkowska, E. (2024) · Advances in food and nutrition research · doi:10.1016/bs.afnr.2023.12.001 · Cited by 7
Maretti, E., Gioia, F., Rustichelli, C., Molinari, S., & Leo, E. (2024) · Molecules · doi:10.3390/molecules29071616 · Cited by 6
Ren, J., Gao, Q., Zhou, X., Chen, L., Guo, W., Feng, K., Hu, J., Huang, T., & Cai, Y. (2024) · Vaccine · doi:10.1016/j.vaccine.2024.126253 · Cited by 7
Hussein, A. A., AL–Mammori, R. T. O., Hassan, F. G., Al-Khafaje, M. E., Saeedi, K. R. H. A., & Al-Charrakh, A. H. (2024) · Medical Journal of Babylon · doi:10.4103/mjbl.mjbl_1060_23 · Cited by 6
Plazas, E., Sierra-Marquez, L., & Olivero‐Verbel, J. (2025) · Molecules · doi:10.3390/molecules30071486 · Cited by 11
Chatterjee, S., Mishra, S., Chowdhury, K. D., Ghosh, C. K., & Saha, K. D. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119580 · Cited by 6
Suhartono, S., Wijaya, I., & Dalimoenthe, N. Z. (2021) · Bali Medical Journal · doi:10.15562/bmj.v10i2.2434 · Cited by 6
Impact of immunosuppression on the immune response to SARS‐CoV‐2 infection: A mechanistic study
Hall, V. G., Ferreira, V. H., Kumar, D., & Humar, A. (2021) · Transplant Infectious Disease · doi:10.1111/tid.13743 · Cited by 6
The immunologic response to severe acute respiratory syndrome coronavirus 2
Le, N. K., Kaman, K., Martin, H. C., Mullur, J., Stenehjem, K. K., Coomar, L. A., Bahar, B., Dutta, M., Izurieta, R., & Brooks, J. P. (2021) · Allergy and Asthma Proceedings · doi:10.2500/aap.2021.42.210077 · Cited by 6
Yadav, D., Agarwal, S., Pancham, P., Jindal, D., Agarwal, V., Dubey, P. K., Jha, S. K., Mani, S., Rachana, R., Dey, A., et al. (2022) · Immuno · doi:10.3390/immuno2020022 · Cited by 7
Jiang, J., Zhong, W., Huang, W., Gao, Y., He, Y., Li, X., Liu, Z., Zhou, H., Fu, Y., Liu, R., et al. (2022) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s361936 · Cited by 6
Wondeu, A. L. D., Talom, B. M., Linardos, G., Ngoumo, B. T., Bello, A., Soufo, A. M. N., Tetsatsi, A. C. M., Doll, C., Tamuedjoun, A. T., Kiuate, J.-R., et al. (2023) · Journal of Public Health in Africa · doi:10.4081/jphia.2023.2242 · Cited by 6
Lesteberg, K. E., Araya, P., Waugh, K. A., Chauhan, L., Espinosa, J. M., & Beckham, J. D. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1113932 · Cited by 7
Awoke, M. A., Adane, A., Assefa, B. S., Getawa, S., Legese, G. L., & yimer, M. (2023) · PubMed Central · Cited by 6
Ahmed, R., Saba, A. A., Paul, A. C., Nur, J., Alam, M. S., Chakraborty, S., Howlader, M. Z. H., Islam, L. N., & Nabi, A. N. (2023) · BioMed Research International · doi:10.1155/2023/5705076 · Cited by 6
Justyn, M., Yulianti, T., & Wilar, G. (2023) · International Journal of Applied Pharmaceutics · doi:10.22159/ijap.2023v15i6.48889 · Cited by 6
SARS-CoV-2 Infection Is an Independent Risk Factor for Decompensation in Cirrhosis Patients
Ayoub, M., Tomanguillo, J., Faris, C., Anwar, N., Chela, H. K., & Daglilar, E. S. (2024) · Diseases · doi:10.3390/diseases12030046 · Cited by 6
Zheng, F., Chen, R., Yao, R., Huang, Y., Tan, X., Liu, J., Li, N., & Xie, Y. (2021) · Infectious Diseases and Therapy · doi:10.1007/s40121-021-00458-y · Cited by 6
Corredor, G., Toro, P., Bera, K., Fu, P., Barton, L. M., Gilmore, H. L., Mukhopadhyay, S., Madabhushi, A., Rasmussen, D., Viswanathan, V. S., et al. (2021) · Journal of medical imaging · doi:10.1117/1.jmi.8.s1.017501 · Cited by 6
Effects of Potential Micro- and Macro-nutrients in Combatting COVID-19
Rocha, J. P., Basra, T., Kurdi, B. E., & Venegas-Borsellino, C. P. (2021) · Current Surgery Reports · doi:10.1007/s40137-021-00301-w · Cited by 6
Animal Models of COVID-19: Nonhuman Primates
Singh, D. K., Cole, J., Escobedo, R. A., Alfson, K. J., Singh, B., Lee, T., Alvarez, X. A., Ganatra, S., Carrion, R., & Kaushal, D. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2111-0_15 · Cited by 5
Homocysteine as a predictor of the severity of coronavirus infection: biochemical justification
Васильевна, В. Н., Gaikovaya, L. B., Евтеева, Д. А., & Vlasova, Y. A. (2022) · Laboratory Service · doi:10.17116/labs20221101143 · Cited by 6
Wang, J., Li, T.-N., Zhou, C., Zhao, J., Wang, M., Wang, Y., Jiang, Y., Dong, H., Qi, Q.-R., & Mu, H. (2022) · Virologica Sinica · doi:10.1016/j.virs.2022.10.009 · Cited by 6
Philips, C. A., Kakkar, K., Joseph, M., Yerol, P. K., Ahamed, R., Rajesh, S., & Augustine, P. (2021) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2020.00110 · Cited by 6
Reactive arthritis following COVID‐19: cause for concern
Migliorini, F., KARLSSON, J. L., & Maffulli, N. (2023) · Knee Surgery Sports Traumatology Arthroscopy · doi:10.1007/s00167-023-07332-z · Cited by 6
Perspective: Food Environment, Climate Change, Inflammation, Diet, and Health
Hébert, J. R., Holmberg, R. H., Boncyk, M., Scott, G. I., Murphy, E. A., & Hofseth, L. J. (2025) · Advances in Nutrition · doi:10.1016/j.advnut.2025.100504 · Cited by 8
Metabolomics and Cytokine Signatures in COVID-19: Uncovering Immunometabolism in Pathogenesis
Banoei, M. M., Shahraki, A. H., Santos, K., Holt, G. E., & Mirsaeidi, M. S. (2025) · Metabolites · doi:10.3390/metabo15090608 · Cited by 6
Murad, D., Paracha, R. Z., Saeed, T., Ahmad, J., Mushtaq, A., & Humayun, M. (2023) · PeerJ · doi:10.7717/peerj.15794 · Cited by 5
Mazzotti, L., de Souza, P. B., Azzali, I., Angeli, D., Nanni, O., Sambri, V., Semprini, S., Bravaccini, S., Cerchione, C., Gaimari, A., et al. (2025) · HLA · doi:10.1111/tan.70011 · Cited by 5
Cuevas-García, C., Calderón-Vallejo, A., & Berrón‐Ruiz, L. (2021) · Revista Alergia México · doi:10.29262/ram.v67i4.828 · Cited by 5
Deb, C., Salinas, A. N., Zheng, T., Middleton, A., Kern, K., Penoyer, D., Borsadia, R., Hunley, C. F., Abomoelak, B., Mehta, V. K., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-02863-2 · Cited by 5
Meneses-Liendo, V., Chávez, M. M., Gómez-Luján, M., Cruzalegui, C., & Alarcon-Ruiz, C. A. (2022) · ACTA MEDICA PERUANA · doi:10.35663/amp.2021.384.2169 · Cited by 5
Kara, U., Şimşek, F., Özhan, M. Ö., İnce, M., Özkan, G., Şenkal, S., & Çoşar, A. (2022) · Journal of Health Sciences and Medicine · doi:10.32322/jhsm.1052191 · Cited by 5
Narayanan, D., & Parimon, T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147702 · Cited by 5
Coronavirus reinfections: An outlook on evidences and effects
Patel, V. K., Shirbhate, E., & Rajak, H. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-99878-9.00013-3 · Cited by 5
Thrombotic storm in coronavirus disease 2019: from underlying mechanisms to its management
Zebardast, A., Latifi, T., Shabani, M., Hasanzadeh, A., Danesh, M., Babazadeh, S., & Sadeghi, F. (2022) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001591 · Cited by 5
Immune Response Gaps Linked to SARS-CoV-2 Infection: Cellular Exhaustion, Senescence, or Both?
Barbosa, L. V., Prá, D. M. M., Nagashima, S., Pereira, M. R. C., Stocco, R. B., da Silva, F. D. L. F., Cruz, M. R., Dallagassa, D., Stupak, T. J., Götz, G. W. X. D. R., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232213734 · Cited by 5
Nisa, A., Kumar, R., Ramasamy, S., Kolloli, A., Olejnik, J., Jalloh, S., Gummuluru, S., Subbian, S., & Bushkin, Y. (2024) · Cells · doi:10.3390/cells13050432 · Cited by 5
The impact of SARS-CoV-2 spike mutation on peptide presentation is HLA allomorph-specific
Ahn, Y. M., Maddumage, J. C., Grant, E. J., Chatzileontiadou, D. S. M., Perera, W. W. J. G., Baker, B. M., Szeto, C. W., & Gras, S. (2024) · Current Research in Structural Biology · doi:10.1016/j.crstbi.2024.100148 · Cited by 5
Long-term cytokine profile in multisystem inflammatory disease among children
Calcaterra, V., Loretelli, C., Biganzoli, D., Abdelsalam, A., Marano, G., Carelli, S., Fiori, L., Mannarino, S., D’Auria, E., Verduci, E., et al. (2024) · Cytokine · doi:10.1016/j.cyto.2024.156744 · Cited by 5
Extensive Arterial Thrombus Following Discharge after a Covid-19 Infection
Baştopçu, M. (2020) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2020.11.008 · Cited by 5
Márquez-González, H., López-Martı́nez, B., Parra‐Ortega, I., de la Rosa‐Zamboni, D., Salazar–García, M., Olivar-López, V. B., & Klünder‐Klünder, M. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2021.671831 · Cited by 5
NEUT-SFL in Patients with COVID-ARDS: A Novel Biomarker for Thrombotic Events?
Stiel, L., Rabouël, Y., Debliquis, A. P., Pointurier, V., Mootien, J., & Kuteifan, K. (2021) · Disease Markers · doi:10.1155/2021/4361844 · Cited by 5
An experimental in silico study on COVID‐19: Response of neutrophil‐related genes to antibiotics
Mousavi, S. R., Lotfi, H., Salmanizadeh, S., Feizbakhshan, S., Khosravian, F., Sajjadi, M. S., Komachali, S. R., Beni, F. A., Torkan, B., Kazemi, M., et al. (2022) · Health Science Reports · doi:10.1002/hsr2.548 · Cited by 5
High Seroprevalence of SARS-COV-2 Antibody before Covid-19 Vaccination in Nigerian Communities
Olaleye, D. O., Aminu, M., Olusola, B., Segun, T., Faneye, A., Opayele, A. V., Odeh, E. C., Sarki, M., Dairo, M., Fagbamigbe, A. F., et al. (2022) · International Archives of Public Health and Community Medicine · doi:10.23937/2643-4512/1710083 · Cited by 5
Milner, J. E., Schwartz, E., Geller, J. S., Constantinescu, D. S., Allegra, P. R., Trapana, J. E., & Vilella, F. E. (2022) · Trauma Care · doi:10.3390/traumacare2040045 · Cited by 5
Efficacy of olocizumab in treatment of COVID-19 patients
Гома, Т. В., Kalyagin, A. N., Рыжкова, О. В., & Soloveva, N. S. (2022) · Бюллетень Восточно-Сибирского научного центра Сибирского отделения Российской академии медицинских наук · doi:10.29413/abs.2022-7.5-2.9 · Cited by 5
Sultana, G. N. N., Srivastava, A., Akhtaar, K., Singh, P. P., Islam, M. A., Rahman, F., & Chaubey, G. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.966595 · Cited by 5
Gentili, V., Bortolotti, D., Morandi, L., Rizzo, S., Schiuma, G., Beltrami, S., Casciano, F., Papi, A. A., Contoli, M., Zauli, G., et al. (2023) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2807156 · Cited by 5
Kurniawan, S. D., Kaisar, M. M. M., Kristin, H., & Ali, S. (2023) · Reviews in Medical Virology · doi:10.1002/rmv.2492 · Cited by 5
Singh, P., Warren, K., Adler, H., Mangano, A., Sansbury, J. R., & Duff, R. (2021) · Cureus · doi:10.7759/cureus.14051 · Cited by 5
Andaluz‐Ojeda, D., Vidal, P., Sanz, Á. A., Suberviola, B., Carbajo, L. D. R., Martín, L. N., Silva, E. P., Olmo, J. N.-D., Barberán, J., & Cusácovich, I. (2022) · World Journal of Critical Care Medicine · doi:10.5492/wjccm.v11.i4.269 · Cited by 6
Ibrahim, I., Škoch, A., Dezortová, M., Adla, T., Flusserová, V., Nagy, M., Douchová, I., Fialová, M., Filová, V., Pajuelo, D., et al. (2024) · Quantitative Imaging in Medicine and Surgery · doi:10.21037/qims-24-162 · Cited by 4
Metadata
- Authors
- García, L. F.
- Affiliations
- Universidad de Antioquia (CO)
- Corresponding author
- García, Luis F.
- ORCID
- García, Luis F.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2020-06-16
- Volume
- 11
- Pages
- 1441-1441
- ISSN
- 1664-3224 (ISSN-L)
- PMC
- PMC7308593
- OpenAlex
- W3035895802
- Cited by
- 739
- References
- 141
- Citations by year
- 2026: 17 · 2025: 30 · 2024: 68 · 2023: 89 · 2022: 172 · 2021: 279 · 2020: 83
- FWCI
- 7.36
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Immunology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Institutional Repository University of Antioquia (University of Antioquia) (publishedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Greater South Information System
- Topics
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Dermatology › Dermatological and COVID-19 studies
- Keywords
- COVID-19 pandemic, SARS-CoV-2, immune response, inflammation, clinical spectrum, immunopathogenesis, disease severity, SARS, MERS, immune regulation, coronavirus infection
- MeSH terms
- Betacoronavirus, COVID-19, SARS-CoV-2, Age Factors, Antibodies, Viral, Humans, Immunoglobulin A, Secretory, Inflammation, Macrophages, Pneumonia, Viral, T-Lymphocytes, Cytokines, Coronavirus Infections, Antibody-Dependent Enhancement, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
